Jeong Anna, Oleske Denise M, Holman Joan
1 AbbVie, Inc, North Chicago, IL, USA.
J Child Neurol. 2019 Oct;34(12):705-712. doi: 10.1177/0883073819845827. Epub 2019 Jun 11.
Multiple sclerosis onset in youth is increasingly recognized. A systematic review was conducted to assess incidence and prevalence of pediatric-onset multiple sclerosis, focusing on occurrence by age subgroups and disease course. A literature search for the period 1965-2018 was carried out, selecting population-based studies of multiple sclerosis in individuals aged 19 years and younger. Nineteen studies met inclusion criteria. One pediatric neurologist extracted the data. Overall incidence ranged from 0.05 (95% confidence interval 0.03-0.08) to 2.85 (95% confidence interval 2.83-2.86) per 100 000 children and overall prevalence from 0.69 (95% confidence interval 0.58-0.80) to 26.92 (95% confidence interval 26.61-27.23) per 100 000 children. Incidence increased with age. The female-male ratio increased from 1.2:1 in children <12 years old to 2.8:1 in children ≥12 years old. Ten studies (n=521 children) reported disease course. Seven studies found only relapsing-remitting disease and 3 studies found primary-progressive disease in 3.0% to 6.7%. Two secondary-progressive disease cases were identified. Epidemiologic data aid in understanding the magnitude of multiple sclerosis and its clinical phenotypes, for planning for new disease-modifying therapies in the pediatric population.
青年期多发性硬化症的发病越来越受到关注。本研究进行了一项系统综述,以评估儿童期发病的多发性硬化症的发病率和患病率,重点关注不同年龄亚组的发病情况和疾病进程。检索了1965年至2018年期间的文献,选取了基于人群的19岁及以下个体的多发性硬化症研究。19项研究符合纳入标准。由一名儿科神经科医生提取数据。每10万名儿童的总体发病率在0.05(95%置信区间0.03 - 0.08)至2.85(95%置信区间2.83 - 2.86)之间,总体患病率在每10万名儿童0.69(95%置信区间0.58 - 0.80)至26.92(95%置信区间26.61 - 27.23)之间。发病率随年龄增长而增加。女性与男性的比例从12岁以下儿童的1.2:1增加到12岁及以上儿童的2.8:1。10项研究(n = 521名儿童)报告了疾病进程。7项研究仅发现复发缓解型疾病,3项研究发现原发进展型疾病的比例为3.0%至6.7%。识别出2例继发进展型疾病病例。流行病学数据有助于了解多发性硬化症的严重程度及其临床表型,为规划针对儿科人群的新型疾病修正疗法提供依据。